Genial Helix L T D

FDA Filings

This page includes the latest FDA filings for Genial Helix L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)
Registration Number3003747162
FEI Number3003747162
NamePeter Mousseau
Owner & OperatorGenial Helix Ltd
Contact AddressUnit 62 CoWorkz Business Centre
Chester GB-FLN Flintshire CH1 4QL GB
Official Correspondent
  • Lawrence Crees
  • 44-01244-757155-x
US Agent
Registration Status1
Initial ImporterN
Registration Expiration2020-04-25
Registration Address83 Maple Avenue
Windsor, CT 06095 US
Establishment TypeManufacture Medical Device



FDA Filings

Device
Company
DeviceDate
GENIAL HELIX LTD
Solid Tumor Growth Supplement GGS - JL0102023-09-26
GENIAL HELIX LTD
Product of Conception Growth Supplement GGS - JL0132023-09-26
GENIAL HELIX LTD
Lymphoma Growth Supplement GGS - JL0112023-09-26
GENIAL HELIX LTD
Skin Growth Supplement GGS - JL0122023-09-26
GENIAL HELIX LTD
Cytoclear Cytoplasm Remover GGS - JL0042023-09-26
GENIAL HELIX LTD
Optimal Hypotonic Solution GGS - JL0052023-09-26
GENIAL HELIX LTD
Buffered Hypotonic Solution GGS - JL0062023-09-26
GENIAL HELIX LTD
Pre-Hypotonic Solution GGS - JL0072023-09-26
GENIAL HELIX LTD
Metaphase Arresting Solution GGS - JL0082023-09-26
GENIAL HELIX LTD
Chromosome Resolution Additive GGS - JL0032023-09-26
GENIAL HELIX LTD
Bone Marrow Growth Supplement GGS - JL0022023-09-26
GENIAL HELIX LTD
Lymphocyte Growth Supplement GGS - JL002L2023-09-26
GENIAL HELIX LTD
Erythrocyte Lysis Solution GGS - JL0092023-09-26
GENIAL HELIX LTD
Anticlotting Reagent GGS - JL0012023-09-26
Peter Mousseau [Genial Helix Ltd]
Solid Tumour Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Skin Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Product of Conception Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Lymphoma Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Lymphocyte Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Bone Marrow Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Pre-Hypotonic Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Optimal Hypotonic Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Metaphase Arresting Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Erythrocyte Lysis Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Cytoclear2019-04-17
Peter Mousseau [Genial Helix Ltd]
Buffered Hypotonic Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Anti-Clotting Reagent2019-04-17

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.